Ferenci, Peter, Bourgeois, Stefan, Buggisch, Peter, Norris, Suzanne, Curescu, Manuela, Larrey, Dominique, Marra, Fiona ORCID: 0000-0003-1326-1149, Kleine, Henning, Dorr, Patrick, Charafeddine, Mariem et al (show 4 more authors)
(2019)
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in hepatitis C virus genotype 1-and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
JOURNAL OF VIRAL HEPATITIS, 26 (6).
685 - 696.
Text
Ferenci_et_al-2019-Journal_of_Viral_Hepatitis.pdf - Published Version Download (594kB) | Preview |
Item Type: | Article |
---|---|
Uncontrolled Keywords: | comorbidity, direct-acting antiviral, drug-drug interaction, hepatitis C virus, real-world evidence |
Depositing User: | Symplectic Admin |
Date Deposited: | 04 Jun 2019 09:11 |
Last Modified: | 09 Jan 2021 03:33 |
DOI: | 10.1111/jvh.13080 |
Open Access URL: | http://doi.org/10.1111/jvh.13080 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3044362 |